Ew Healthcare Partners Fund 2, L.P.'s Form 4 filing
TELA Bio, Inc. (TELA) · filed Nov 23, 2021
- Accession no.
- 0000899243-21-045832
- Filed
- Nov 23, 2021, 5:40 PM ET
- Trade date
- Nov 22-23, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $47.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ew Healthcare Partners Fund 2, L.P.CIK 0001746777 | Other: See footnote 2 |
| Ew Healthcare Partners Fund 2-A, L.P.CIK 0001746779 | Other: See footnote 2 |
| EW Healthcare Partners Fund 2 GP, L.P.CIK 0001793943 | 10% Owner |
| EW Healthcare Partners Fund 2-UGP, LLCCIK 0001793948 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +3,295 | $12.49 | +$41,154.55 | 1,851,474 | Indirect | |
| Nov 23, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +516 | $12.49 | +$6,444.84 | 1,851,990 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.